Delivery Order SPE2DB20D3101-SPE2DB24FREE4

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,161.88, is for the supply of 4,568,060,828 units of Dexmethylphenidate ER 10 mg capsules. The contract has a period of performance through April 29, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,713.60, is for the delivery of 4,567,873,443 units of Dexmethylphenidate ER 10 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 11, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.79, is for the delivery of 4,567,962 units of the medication Dexmethylphenidate ER 10 mg capsules over a performance period ending on April 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,954,905 units of the prescription medication dexmethylphenidate ER 10 mg capsules, with a total ceiling value of $1,141.59. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,237.10 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,625,337 units of Dexmethylphenidate ER 10 mg capsules. The contract is a firm fixed-price agreement with an ultimate completion date of August 29, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,565,240,637 units of Dexmethylphenidate ER 10 mg capsules. The firm-fixed-price contract has a total ceiling value of $1,594.92 and a completion date of July 25, 2024. There is no set-aside designation for this award. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medications and medical supplies...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,439.23, is for the delivery of 4,567,748,344 units of Dexmethylphenidate ER 25 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,060,860 units of the drug Dexmethylphenidate ER 20 mg capsules, with a ceiling value of $4,639.84. The contract is a firm fixed-price delivery order, with a performance period ending on April 29, 2025. This contract is not set-aside and was competed openly. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,192.88 firm fixed-price delivery order is for the supply of 4,566,552,109 units of Dexmethylphenidate ER 10 mg capsules. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $21,014.33, is for the delivery of 4,563,924,228 units of Dexmethylphenidate ER 20 MG capsules. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen is a for-profit organization that is a key vendor...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FREE4
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,064.99, is for the delivery of 4,564,027,162 units of the medication Dexmethylphenidate ER 20 mg capsules. The contract is a firm fixed-price delivery order with a period of performance through March 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's role as a critical vendor for the DLA in supplying essential medications to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/27/25, 10:54 AM